KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner

JY Qian, J Gao, X Sun, MD Cao, L Shi, TS Xia… - Oncogene, 2019 - nature.com
Abstract Most N6-methyladenosine (m6A) associated regulatory proteins (ie, m6A writer,
eraser, and reader proteins) are involved in the pathogenesis of various cancers, mostly in …
被引用次数：181 相关文章

KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner

JY Qian, J Gao, X Sun, MD Cao, L Shi, TS Xia… - Oncogene, 2019 - go.gale.com
Most N6-methyladenosine (m. sup. 6A) associated regulatory proteins (ie, m. sup. 6A writer,
eraser, and reader proteins) are involved in the pathogenesis of various cancers, mostly in …

KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner

JY Qian, J Gao, X Sun, MD Cao, L Shi, TS Xia… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Most N6-methyladenosine (m 6 A) associated regulatory proteins (ie, m 6 A writer, eraser,
and reader proteins) are involved in the pathogenesis of various cancers, mostly in m 6 A …

KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner.

JY Qian, J Gao, X Sun, MD Cao, L Shi, TS Xia… - Oncogene, 2019 - europepmc.org
Most N6-methyladenosine (m 6 A) associated regulatory proteins (ie, m 6 A writer, eraser,
and reader proteins) are involved in the pathogenesis of various cancers, mostly in m 6 A …